pipobroman has been researched along with Myeloproliferative Disorders in 3 studies
Pipobroman: An antineoplastic agent that acts by alkylation.
pipobroman : An N-acylpiperazine that is piperazine in which each of the nitrogens has been acylated by a 3-bromopropionoyl group. An anti-cancer drug.
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Relapses occurred in 30% of the cases but responded to pipobroman at the initial high dosage level." | 1.26 | [Management of polycythaemia with pipobroman]. ( Duhamel, G; Gorin, NC; Najman, A; Parlier, Y; Perreau-Boutet, MC; Stachowiak, J, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abruzzese, E | 1 |
| Trawinska, MM | 1 |
| Neri, B | 1 |
| Bondanini, F | 1 |
| Fratoni, S | 1 |
| Tendas, A | 1 |
| Scaramucci, L | 1 |
| Siniscalchi, A | 1 |
| Giovannini, M | 1 |
| Palumbo, R | 1 |
| de Fabritiis, P | 1 |
| Niscola, P | 2 |
| Andriani, A | 1 |
| Elli, E | 1 |
| Trapè, G | 1 |
| Villivà, N | 1 |
| Fianchi, L | 1 |
| Di Veroli, A | 1 |
| Centra, A | 1 |
| Anaclerico, B | 1 |
| Montanaro, G | 1 |
| Martini, V | 1 |
| Aroldi, A | 1 |
| Carmosino, I | 1 |
| Voso, MT | 1 |
| Breccia, M | 1 |
| Montanaro, M | 1 |
| Foà, R | 1 |
| Latagliata, R | 1 |
| Perreau-Boutet, MC | 1 |
| Najman, A | 1 |
| Stachowiak, J | 1 |
| Parlier, Y | 1 |
| Gorin, NC | 1 |
| Duhamel, G | 1 |
3 other studies available for pipobroman and Myeloproliferative Disorders
| Article | Year |
|---|---|
Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm.
Topics: Aged; Decitabine; Female; Humans; Hydroxyurea; Janus Kinase 2; Leukemia, Myeloid, Acute; Male; Myelo | 2018 |
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Blast Crisis; Female; Humans; Hydroxyurea; Leuke | 2019 |
[Management of polycythaemia with pipobroman].
Topics: Female; Humans; Leukemia; Male; Myeloproliferative Disorders; Pipobroman; Polycythemia; Polycythemia | 1982 |